BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27503693)

  • 1. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
    Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the medical management of endometriosis.
    Panay N
    BJOG; 2008 Jun; 115(7):814-7. PubMed ID: 18485157
    [No Abstract]   [Full Text] [Related]  

  • 8. Endometriosis management: workflow on genomics and proteomics and future biomolecular pharmacotherapy.
    Tinelli A; Martignago R; Vergara D; Leo G; Malvasi A; Tinelli R
    Curr Med Chem; 2008; 15(21):2099-107. PubMed ID: 18781937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational drugs for endometriosis.
    Chlouber RO; Olive DL; Pritts EA
    Expert Opin Investig Drugs; 2006 Apr; 15(4):399-407. PubMed ID: 16548789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New medical treatments for endometriosis.
    Olive DL; Lindheim SR; Pritts EA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):319-28. PubMed ID: 15157645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
    Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
    Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.
    Reis FM; Coutinho LM; Vannuccini S; Batteux F; Chapron C; Petraglia F
    Hum Reprod Update; 2020 Jun; 26(4):565-585. PubMed ID: 32412587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of endometriosis. An update].
    Socolov R; Buţureanu S; Socolov D; Sindilar A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1064-9. PubMed ID: 21500460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Bartels CB; Cayton KC; Chuong FS; Holthouser K; Arian SE; Abraham T; Segars JH
    Clin Obstet Gynecol; 2016 Mar; 59(1):30-52. PubMed ID: 26756261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor ligands for the treatment of endometriosis.
    Clemenza S; Capezzuoli T; Eren E; Garcia Garcia JM; Vannuccini S; Petraglia F
    Minerva Obstet Gynecol; 2023 Jun; 75(3):288-297. PubMed ID: 36255163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovations in classical hormonal targets for endometriosis.
    Pluchino N; Freschi L; Wenger JM; Streuli I
    Expert Rev Clin Pharmacol; 2016; 9(2):317-27. PubMed ID: 26645363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Zajec V; Mikuš M; Vitale SG; D'alterio MN; Gregov M; Šarić MJ; Carugno J; Angioni S; Ćorić M
    Gynecol Endocrinol; 2022 Sep; 38(9):713-720. PubMed ID: 35971323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor.
    Iwase H
    Int J Clin Oncol; 2015 Apr; 20(2):249-52. PubMed ID: 25666484
    [No Abstract]   [Full Text] [Related]  

  • 20. New developments in the medical treatment of endometriosis.
    Bedaiwy MA; Alfaraj S; Yong P; Casper R
    Fertil Steril; 2017 Mar; 107(3):555-565. PubMed ID: 28139238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.